The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation

Franziska Oberhammer, Peter Naoy, Roman Tiefenbacher, Gertraud Fröschl, Boumediene Bouzahzah, Snorri S. Thorgeirsson, Brian Carr

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recently, cases of liver damage and liver tumors have been reported after treatment of prostate cancer patients with the antiandrogen cyproterone acetate (CPA). In rat liver, CPA initiates a wave of DNA synthesis that is accompanied by apoptosis. In apoptotic hepatocytes, a latent form of transforming growth factor β1 (TGF-β1) is detectable by immunohistochemistry. Injection of a single dose of TGF-β1 induces apoptosis in the liver of animals pretreated with CPA but has an insignificant effect in untreated animals. In this study, we show by Northern analysis that there is increased expression of TGF-β1 in the liver after CPA treatment. Detection of TGF-β1 with in situ hybridization showed that TGF-β1 was synthesized in the parenchymal cells. Time course and dose-response experiments performed 48 hours after the last application of CPA showed that apoptotic nuclei with chromatin condensed at the nuclear periphery (AN) were already visible 2 hours after injection (0.13%), and apoptotic bodies (ABs) increased 2 to 9 hours after the injection (from 1.28% to 6.67%) after 25 μg TGF-β1/kg. At 4.5 hours after injection, an induction of apoptosis could be detected with 0.25 μg TGF-β1/kg and after the maximum dose (250 μg TGF-β1/kg) ANs (0.24%) and ABs (16.74%) were homogeneously distributed throughout the liver lobe. Irrespective of the dose or time after injection of TGF-β1, 82% of the ABs were localized within hepatocytes. Liver enzymes were detected in high amounts in the serum (eightfold elevation of glutamate dehydrogenase, fivefold elevation of alanine transaminase [ALT]) 7 hours after the first visible sign of apoptosis. After an additional 20 hours, the liver contained many necrotic figures. These results suggest that the combination of TGF-β1 expression coupled with a strikingly enhanced sensitivity to the induction of apoptosis could be responsible both for the liver damage and the development of liver tumors observed after treatment with CPA.

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalHepatology
Volume23
Issue number2
Publication statusPublished - 1996

Fingerprint

Cyproterone Acetate
Androgen Antagonists
Transforming Growth Factors
Necrosis
Apoptosis
Inflammation
Liver
Injections
Hepatocytes
Glutamate Dehydrogenase
Alanine Transaminase
Chromatin
In Situ Hybridization
Neoplasms
Prostatic Neoplasms
Therapeutics
Immunohistochemistry

ASJC Scopus subject areas

  • Hepatology

Cite this

The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. / Oberhammer, Franziska; Naoy, Peter; Tiefenbacher, Roman; Fröschl, Gertraud; Bouzahzah, Boumediene; Thorgeirsson, Snorri S.; Carr, Brian.

In: Hepatology, Vol. 23, No. 2, 1996, p. 329-337.

Research output: Contribution to journalArticle

Oberhammer, Franziska ; Naoy, Peter ; Tiefenbacher, Roman ; Fröschl, Gertraud ; Bouzahzah, Boumediene ; Thorgeirsson, Snorri S. ; Carr, Brian. / The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. In: Hepatology. 1996 ; Vol. 23, No. 2. pp. 329-337.
@article{6b4df3e82f7948da8f10a815e546ea5f,
title = "The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation",
abstract = "Recently, cases of liver damage and liver tumors have been reported after treatment of prostate cancer patients with the antiandrogen cyproterone acetate (CPA). In rat liver, CPA initiates a wave of DNA synthesis that is accompanied by apoptosis. In apoptotic hepatocytes, a latent form of transforming growth factor β1 (TGF-β1) is detectable by immunohistochemistry. Injection of a single dose of TGF-β1 induces apoptosis in the liver of animals pretreated with CPA but has an insignificant effect in untreated animals. In this study, we show by Northern analysis that there is increased expression of TGF-β1 in the liver after CPA treatment. Detection of TGF-β1 with in situ hybridization showed that TGF-β1 was synthesized in the parenchymal cells. Time course and dose-response experiments performed 48 hours after the last application of CPA showed that apoptotic nuclei with chromatin condensed at the nuclear periphery (AN) were already visible 2 hours after injection (0.13{\%}), and apoptotic bodies (ABs) increased 2 to 9 hours after the injection (from 1.28{\%} to 6.67{\%}) after 25 μg TGF-β1/kg. At 4.5 hours after injection, an induction of apoptosis could be detected with 0.25 μg TGF-β1/kg and after the maximum dose (250 μg TGF-β1/kg) ANs (0.24{\%}) and ABs (16.74{\%}) were homogeneously distributed throughout the liver lobe. Irrespective of the dose or time after injection of TGF-β1, 82{\%} of the ABs were localized within hepatocytes. Liver enzymes were detected in high amounts in the serum (eightfold elevation of glutamate dehydrogenase, fivefold elevation of alanine transaminase [ALT]) 7 hours after the first visible sign of apoptosis. After an additional 20 hours, the liver contained many necrotic figures. These results suggest that the combination of TGF-β1 expression coupled with a strikingly enhanced sensitivity to the induction of apoptosis could be responsible both for the liver damage and the development of liver tumors observed after treatment with CPA.",
author = "Franziska Oberhammer and Peter Naoy and Roman Tiefenbacher and Gertraud Fr{\"o}schl and Boumediene Bouzahzah and Thorgeirsson, {Snorri S.} and Brian Carr",
year = "1996",
language = "English",
volume = "23",
pages = "329--337",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation

AU - Oberhammer, Franziska

AU - Naoy, Peter

AU - Tiefenbacher, Roman

AU - Fröschl, Gertraud

AU - Bouzahzah, Boumediene

AU - Thorgeirsson, Snorri S.

AU - Carr, Brian

PY - 1996

Y1 - 1996

N2 - Recently, cases of liver damage and liver tumors have been reported after treatment of prostate cancer patients with the antiandrogen cyproterone acetate (CPA). In rat liver, CPA initiates a wave of DNA synthesis that is accompanied by apoptosis. In apoptotic hepatocytes, a latent form of transforming growth factor β1 (TGF-β1) is detectable by immunohistochemistry. Injection of a single dose of TGF-β1 induces apoptosis in the liver of animals pretreated with CPA but has an insignificant effect in untreated animals. In this study, we show by Northern analysis that there is increased expression of TGF-β1 in the liver after CPA treatment. Detection of TGF-β1 with in situ hybridization showed that TGF-β1 was synthesized in the parenchymal cells. Time course and dose-response experiments performed 48 hours after the last application of CPA showed that apoptotic nuclei with chromatin condensed at the nuclear periphery (AN) were already visible 2 hours after injection (0.13%), and apoptotic bodies (ABs) increased 2 to 9 hours after the injection (from 1.28% to 6.67%) after 25 μg TGF-β1/kg. At 4.5 hours after injection, an induction of apoptosis could be detected with 0.25 μg TGF-β1/kg and after the maximum dose (250 μg TGF-β1/kg) ANs (0.24%) and ABs (16.74%) were homogeneously distributed throughout the liver lobe. Irrespective of the dose or time after injection of TGF-β1, 82% of the ABs were localized within hepatocytes. Liver enzymes were detected in high amounts in the serum (eightfold elevation of glutamate dehydrogenase, fivefold elevation of alanine transaminase [ALT]) 7 hours after the first visible sign of apoptosis. After an additional 20 hours, the liver contained many necrotic figures. These results suggest that the combination of TGF-β1 expression coupled with a strikingly enhanced sensitivity to the induction of apoptosis could be responsible both for the liver damage and the development of liver tumors observed after treatment with CPA.

AB - Recently, cases of liver damage and liver tumors have been reported after treatment of prostate cancer patients with the antiandrogen cyproterone acetate (CPA). In rat liver, CPA initiates a wave of DNA synthesis that is accompanied by apoptosis. In apoptotic hepatocytes, a latent form of transforming growth factor β1 (TGF-β1) is detectable by immunohistochemistry. Injection of a single dose of TGF-β1 induces apoptosis in the liver of animals pretreated with CPA but has an insignificant effect in untreated animals. In this study, we show by Northern analysis that there is increased expression of TGF-β1 in the liver after CPA treatment. Detection of TGF-β1 with in situ hybridization showed that TGF-β1 was synthesized in the parenchymal cells. Time course and dose-response experiments performed 48 hours after the last application of CPA showed that apoptotic nuclei with chromatin condensed at the nuclear periphery (AN) were already visible 2 hours after injection (0.13%), and apoptotic bodies (ABs) increased 2 to 9 hours after the injection (from 1.28% to 6.67%) after 25 μg TGF-β1/kg. At 4.5 hours after injection, an induction of apoptosis could be detected with 0.25 μg TGF-β1/kg and after the maximum dose (250 μg TGF-β1/kg) ANs (0.24%) and ABs (16.74%) were homogeneously distributed throughout the liver lobe. Irrespective of the dose or time after injection of TGF-β1, 82% of the ABs were localized within hepatocytes. Liver enzymes were detected in high amounts in the serum (eightfold elevation of glutamate dehydrogenase, fivefold elevation of alanine transaminase [ALT]) 7 hours after the first visible sign of apoptosis. After an additional 20 hours, the liver contained many necrotic figures. These results suggest that the combination of TGF-β1 expression coupled with a strikingly enhanced sensitivity to the induction of apoptosis could be responsible both for the liver damage and the development of liver tumors observed after treatment with CPA.

UR - http://www.scopus.com/inward/record.url?scp=0030067146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030067146&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 329

EP - 337

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -